BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Response to oxidative stress
,
Arthritis
,
Lymphocyte
,
Human chorionic gonadotropin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
vascular endothelial growth factor receptor
Summary
General Info
Curated Studies
Most Correlated Studies
Human umbilical vein endothelial cells (HUVECs) adhering to soluble VEGFR1 or fibronectin
L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
L1000 CMAP - Lung cancer A549 cells treated with ligand perturbagens
L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
Role of Arginine Methylation in Alternative Polyadenylation of VEGFR-1 (Flt-1) pre-mRNA.
Vascular Endothelial Growth Factor Receptor 1 Targeting Fusion Polypeptides with Stimuli-Responsiven…
Immunohistochemical expression of VEGFR1 in non small cell lung carcinomas: Lower VEGFR1 expression …
Interaction of Some Amino-Nitrile Derivatives with Vascular Endothelial Growth Factor Receptor 1 (VE…
Determination of serum vascular endothelial growth factor (VEGF) and VEGF receptor levels with VEGF …
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Evaluation of Reporting of Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor…
Use of Pan-Vascular Endothelial Growth Factor Receptor (Pan-VEGF) Blockade for the Treatment of Reti…
Soluble Vascular Endothelial Growth Factor Receptor 2 as Predictor of Benefit From Bevacizumab Beyon…
A Study of HLX06, a Humanized Monoclonal Antibody Targeting Human Vascular Endothelial Growth Factor…
A Study of RO4929097 in Patients With Advanced Renal Cell Carcinoma That Have Failed Vascular Endoth…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ